401 related articles for article (PubMed ID: 9853256)
1. AVPR2 variants and V2 vasopressin receptor function in nephrogenic diabetes insipidus.
Wildin RS; Cogdell DE; Valadez V
Kidney Int; 1998 Dec; 54(6):1909-22. PubMed ID: 9853256
[TBL] [Abstract][Full Text] [Related]
2. Novel vasopressin type 2 (AVPR2) gene mutations in Brazilian nephrogenic diabetes insipidus patients.
Boson WL; Della Manna T; Damiani D; Miranda DM; Gadelha MR; Liberman B; Correa H; Romano-Silva MA; Friedman E; Silva FF; Ribeiro PA; De Marco L
Genet Test; 2006; 10(3):157-62. PubMed ID: 17020465
[TBL] [Abstract][Full Text] [Related]
3. Identification and characterization of a novel X-linked AVPR2 mutation causing partial nephrogenic diabetes insipidus: a case report and review of the literature.
Neocleous V; Skordis N; Shammas C; Efstathiou E; Mastroyiannopoulos NP; Phylactou LA
Metabolism; 2012 Jul; 61(7):922-30. PubMed ID: 22386940
[TBL] [Abstract][Full Text] [Related]
4. Nephrogenic diabetes insipidus caused by mutation of Tyr205: a key residue of V2 vasopressin receptor function.
Sangkuhl K; Römpler H; Busch W; Karges B; Schöneberg T
Hum Mutat; 2005 May; 25(5):505. PubMed ID: 15841479
[TBL] [Abstract][Full Text] [Related]
5. AVPR2 variants and mutations in nephrogenic diabetes insipidus: review and missense mutation significance.
Spanakis E; Milord E; Gragnoli C
J Cell Physiol; 2008 Dec; 217(3):605-17. PubMed ID: 18726898
[TBL] [Abstract][Full Text] [Related]
6. A novel AVPR2 splice site mutation leads to partial X-linked nephrogenic diabetes insipidus in two brothers.
Schernthaner-Reiter MH; Adams D; Trivellin G; Ramnitz MS; Raygada M; Golas G; Faucz FR; Nilsson O; Nella AA; Dileepan K; Lodish M; Lee P; Tifft C; Markello T; Gahl W; Stratakis CA
Eur J Pediatr; 2016 May; 175(5):727-33. PubMed ID: 26795631
[TBL] [Abstract][Full Text] [Related]
7. Functional characterization of novel loss-of-function mutations in the vasopressin type 2 receptor gene causing nephrogenic diabetes insipidus.
Böselt I; Tramma D; Kalamitsou S; Niemeyer T; Nykänen P; Gräf KJ; Krude H; Marenzi KS; Di Candia S; Schöneberg T; Schulz A
Nephrol Dial Transplant; 2012 Apr; 27(4):1521-8. PubMed ID: 21917732
[TBL] [Abstract][Full Text] [Related]
8. Functional characterization of the molecular defects causing nephrogenic diabetes insipidus in eight families.
Pasel K; Schulz A; Timmermann K; Linnemann K; Hoeltzenbein M; Jääskeläinen J; Grüters A; Filler G; Schöneberg T
J Clin Endocrinol Metab; 2000 Apr; 85(4):1703-10. PubMed ID: 10770218
[TBL] [Abstract][Full Text] [Related]
9. V2R mutations and nephrogenic diabetes insipidus.
Bichet DG
Prog Mol Biol Transl Sci; 2009; 89():15-29. PubMed ID: 20374732
[TBL] [Abstract][Full Text] [Related]
10. Nephrogenic diabetes insipidus.
Bichet DG
Adv Chronic Kidney Dis; 2006 Apr; 13(2):96-104. PubMed ID: 16580609
[TBL] [Abstract][Full Text] [Related]
11. [Identification of mutations in the arginine vasopressin receptor 2 gene in congenital nephrogenic diabetes insipidus patients].
Gu F; Shi Y; Deng J; Jin Z
Zhonghua Yi Xue Za Zhi; 2002 Oct; 82(20):1401-5. PubMed ID: 12509923
[TBL] [Abstract][Full Text] [Related]
12. Genetic forms of nephrogenic diabetes insipidus (NDI): Vasopressin receptor defect (X-linked) and aquaporin defect (autosomal recessive and dominant).
Bichet DG; Bockenhauer D
Best Pract Res Clin Endocrinol Metab; 2016 Mar; 30(2):263-76. PubMed ID: 27156763
[TBL] [Abstract][Full Text] [Related]
13. Functional characterization of vasopressin receptor 2 mutations causing partial and complete congenital nephrogenic diabetes insipidus in Thai families.
Sahakitrungruang T; Tee MK; Rattanachartnarong N; Shotelersuk V; Suphapeetiporn K; Miller WL
Horm Res Paediatr; 2010; 73(5):349-54. PubMed ID: 20389105
[TBL] [Abstract][Full Text] [Related]
14. Nephrogenic diabetes insipidus.
Bichet DG
Am J Med; 1998 Nov; 105(5):431-42. PubMed ID: 9831428
[TBL] [Abstract][Full Text] [Related]
15. [Hereditary nephrogenic diabetes insipidus].
Morin D; Ala Y; Dumas R
Arch Pediatr; 1995 Jun; 2(6):560-7. PubMed ID: 7640759
[TBL] [Abstract][Full Text] [Related]
16. Identification of mutations in the arginine vasopressin receptor 2 gene causing nephrogenic diabetes insipidus in Chinese patients.
Chen CH; Chen WY; Liu HL; Liu TT; Tsou AP; Lin CY; Chao T; Qi Y; Hsiao KJ
J Hum Genet; 2002; 47(2):66-73. PubMed ID: 11916004
[TBL] [Abstract][Full Text] [Related]
17. Vasopressin type 2 receptor V88M mutation: molecular basis of partial and complete nephrogenic diabetes insipidus.
Bockenhauer D; Carpentier E; Rochdi D; van't Hoff W; Breton B; Bernier V; Bouvier M; Bichet DG
Nephron Physiol; 2010; 114(1):p1-10. PubMed ID: 19816050
[TBL] [Abstract][Full Text] [Related]
18. Physiopathology and diagnosis of nephrogenic diabetes insipidus.
Devuyst O
Ann Endocrinol (Paris); 2012 Apr; 73(2):128-9. PubMed ID: 22503803
[TBL] [Abstract][Full Text] [Related]
19. The property of a novel v2 receptor mutant in a patient with nephrogenic diabetes insipidus.
Inaba S; Hatakeyama H; Taniguchi N; Miyamori I
J Clin Endocrinol Metab; 2001 Jan; 86(1):381-5. PubMed ID: 11232028
[TBL] [Abstract][Full Text] [Related]
20. A female with X-linked Nephrogenic diabetes insipidus in a family with inherited central diabetes Insipidus: Case report and review of the literature.
Ding C; Beetz R; Rittner G; Bartsch O
Am J Med Genet A; 2020 May; 182(5):1032-1040. PubMed ID: 32073219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
